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1. Introduction 
As has been shown by us [ 1,2] and by others 
[3-51, intravenous or intraperitoneal injection of 
large amounts of fructose rapidly depletes liver 
adenosine triphosphate and inorganic phosphate in 
laboratory animals and human individuals. This 
probably interferes with many kinds of energy- 
requiring processes in the liver. We have previously 
shown that incorporation of 14C-leucine into liver 
protein is transiently but strongly inhibited by intra- 
venous administration of 5 mmoles per kg of D- 
fructose to rats [l] The inhibition is maximal 2 to 5 
min after the fructose injection and is practically 
over 25 min later. The inhibition is closely correlated 
with concomitant alterations in liver adenosine tri- 
phosphate [ 11. 
The data presented here indicates that liver poly- 
some profiles are essentially unaltered 5 min after the 
fructose injection. At 15 to 30 min, however, a 
marked disaggregation of large polysomes takes place. 
Determination of Mg 2+ levels in plasma and in liver, 
kidney and heart homogenates indicates that Mg2+ is 
selectively released from the liver (and, to some ex- 
tent, from the kidney) to the blood. Changes in hepa- 
tic levels of free Mg2+ are thought to be involved in 
the alterations of the polysome profiles. 
2. Materials and methods 
The test animals were female albino rats weighing 
180 to 200 g. They were fasted overnight prior to the 
experiments. Liver ribosomes were isolated at various 
North-Holland Publishing Company - Amsterdam 
times relative to an intravenous injection of 5 mmoles 
per kg of D-fructose into the inferior vena cava ex- 
posed to laparatomy under pentobarbital anesthesia. 
Samples of liver were rapidly removed, weighed, and 
homogenized in cold Tris buffer (25 mM Tris, 25 mM 
NaCl, and 5 mM MgCl,) containing 0.14 M sucrose 
and 100 pg/ml of heparin, using seven strokes of a 
Potter-Elvehjem type homogenizer. Deoxycholate 
and Triton X-100 were added from a 5% stock solu- 
tion in distilled water to a final concentration of 1% 
for each, and the tissue was homogenized with two 
more strokes [6]. The resulting 10% liver homogenate 
was centrifuged for 5 min at 30,000 g. Supernatant 
(0.2 ml) was layered over a 0.5 ~ 1.5 M linear sucrose 
gradient made in the above buffer plus 40 pg/ml of 
heparin and centrifuged for 60 min at 192,000 gmax 
in the SW 50.1 rotor. The gradients were analyzed by 
passing them though a 2 mm Gilford flow cell con- 
nected to a Zeiss PMQ II recording spectrophotometer. 
Transmittance at 260 nm was recorded and converted 
to absorbance units. These were multiplied by 5 to 
correct for the 2 mm light path of the flow cell. 
Mg2+ and Ca2+ in plasma and Mg2+ in liver, 
kidney, and heart homogenates were determined with 
a Varian Techtron Model 1000 atomic absorption 
spectrophotometer at appropriate dilutions. Total 
tissue homogenates were made in doubly distilled 
water with deoxycholate and Triton X-100 added as 
above. After a 5 min centrifugation at 3O,OOOg, the 
supernatant was used for Mg2+ determinations. Liver 
* Part of this study was presented at the Symposium on 
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soluble cytosolic and microsomal fractions were 
prepared by homogenizing a weighed sample of liver 
in 5 vol of Tris buffer (25 mM Tris-HCl, pH 7.5, and 
25 mM KCl) containing 0.25 M sucrose. After seven 
strokes of the Potter-Elvehjem homogenizer and a 
10 min centrifugation at 8,000 g, a portion of the 
supernatant corresponding to 1 g of liver fresh weight 
was centrifuged for 2 hr at 105,OOOg. The middle l/3 
of the supernatant was removed with a Pasteur pipette 
for Mg 2+ determinations. The centrifuge tube was 
drained and the microsomal pellet was suspended and 
homogenized in 1% deoxycholate plus 1% Triton 
X- 100 for Mg 2+ determinations. 
3. Results and discussion 
We have previously shown that the incorporation 
of 14C-leucine into liver protein is strongly inhibited 
2 to 5 min after intravenous fructose administration 
to less than 10% of the control value [ 11. The fructose 
effect is brief and by 30 min the value is again at the 
initial level. Comparison of the time courses of the 
changes in ATP levels and 14C-leucine incorporation 
indicates a good correlation between these two 
variables [l] . In other test systems, the level of intra- 
cellular ATP and incorporation of radioactive amino 
acid into protein show an analogous correlation, al- 
though the time course may differ depending on the 
method used to alter the ATP level [7-91. 
The sedimentation characteristics of liver total 
polysomal population before and at various times 
relative to the fructose injection are shown in fig. 1. 
The dose was identical to that used previously when 
14C-leucine incorporation was measured [I]. The 
size distribution of the ribosomes remains essentially 
unchanged at the time of the maximal inhibition of 
14C-leucine incorporation probably indicating an im- 
paired aminoacylation. At 15 and 30 min, however, 
a marked gradual disaggregation of the large poly- 
somes into monosomes is observed which suggests 
that the ribosomes are incapable of initiating a new 
cycle of peptide synthesis. Although the precise rela- 
tionship between fructose administration and altered 
liver polysome profiles remains to be determined, 
changes in intracellular free Mg2+ levels may be in- 
volved. 
The data in table 1 indicate that after fructose ad- 
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Fig. 1. Polysome profiles from rat liver (A) before, (B) 5 min, 
(C) 15 min, (D) 30 min after an intravenous injection of 5 
mmoles per kg of D-fructose. Polysomes were analyzed and 
centrifuged as described in the text. Direction of sedimenta- 
tion in the sucrose gradient is from right to left. Location of 
the monosome peak is indicated by an arrow in (A). 
ministration a significant increase of Mg2+ takes place 
in plasma. The increase is even more marked when the 
Mg2+ values are expressed relative to plasma Ca2+ or 
protein. These ratios are used to correct for the dilu- 
tion effect due to the injection of different test com- 
pounds. 
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Table 1 
Plasma Mg2+ levels 30 min after an intravenous injection of different test compounds. 
Compound 
injected 
No. 
of experiments 
mM 
Plasma Mg2+ 
Mg’+/Ca’+ Mg’+/protein 
(nmoles/mg) 
None 7 0.74 + 0.03 0.30 f. 0.02 15.4 + 0.7 
D-fructose 6 0.85 ? 0.03 + 0.41 ? 0.01 * 23.2 + 0.8 * 
D-glucose 5 0.72 t 0.03 0.33 i 0.01 15.8 * 0.3 
Saline 5 0.79 * 0.02 0.36 * 0.02 16.5 * 0.4 
5 mmoles per kg of fructose, or glucose, or an equivalent volume of saline was injected into the inferior vena cava under pentobar- 
bital anesthesia. For further experimental details, see text. Values are means * S.E., + = P < 0.02, * = P < 0.01, as compared to 
None value. 
Table 2 
Mg2+ in total liver homogenate, in 100,000 g supernatant, and in microsomal fraction 30 min after an intravenous injection of 
of different test compounds. 
~- 
Compound 
injected 
No. 
of experiments 
Mg*+ (pmoles/g liver fresh weight) 
Total homogenate 100,000 g supernatant Microsomal fraction 
None 6 9.03 + 0.17 9.66 ?- 0.03 13.30 * 0.04 
D-fructose 5 7.99 f 0.02 * 8.41 * 0.02 * 12.15 * 0.06 + 
D-glucose 5 9.38 t 0.02 9.52 ? 0.01 13.55 ? 0.06 
Saline 4 8.94 + 0.02 9.49 t 0.02 13.95 * 0.05 
Experimental conditions etc. as in table 1. 
Table 3 
Mg*+ in kidney and heart homogenates 30 min after an intravenous injection of different test compounds. 
Compound 
injected 
No. 
of experiments 
Mg2+ (pmoles/g tissue fresh weight) 
Kidney Heart 
None 7 8.01 ? 0.12 8.38 * 0.09 
D-fructose 5 7.21 * 0.18 * 8.27 + 0.09 
D-glucose 5 8.51 * 0.30 8.73 + 0.48 
Saline 5 7.94 + 0.19 8.41 * 0.17 
Experimental conditions etc. as in table 1. 
Mg 2+ determinations in total liver, kidney, and 
heart homogenates indicate that injection of fructose 
results in a selective loss of Mg2+ from the liver (and, 
to some extent, from the kidney) to the blood (tables 
2 and 3). We have previously shown that, in addition 
to the changes in liver ATP content, a moderate de- 
pression of ATP is also induced in the kidney by D- 
fructose [2]. This reflects the activity of fructokinase 
in these tissues [lo]. In heart, however, this enzyme 
is absent and no changes in ATP [2] or Mg2+ (table 3) 
were observed. The control compounds, an equimolar 
amount of D-glucose and an equivalent volume of 
saline, did not significantly alter the Mg2+ levels in 
any of the test situations. 
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Protein synthesis in the cytoplasm of eukaryotic 
cells takes place on both free and membrane-bound 
polyribosomes. A number of reports have provided 
evidence that separate functions exist for the two 
populations of polyribosomes. Therefore, it was of 
interest to examine the changes in Mg2+ levels in 
soluble cytosolic and microsomal fractions separately. 
The results in table 2 show that, in both these liver 
subfractions, a significant decrease of Mg*+ takes 
place after fructose administration. 
A large part of the Mg2+ present in the cell is 
bound to ATP. Due to the high association constant 
[ 111, as much as 30 to 40% of intracellular Mg2+ 
may be normally bound to ATP, assuming that there 
is no competition by other cations. Fructose injec- 
tion results in. within a few minutes from the injec- 
tion, a decrease of liver ATP to about 40% of the 
initial value [ 11. Subsequently, part of the intracellu- 
lar Mg *+ is released to the interstitial fluid and blood 
as demonstrated in this study. A related phenomenon 
may be an increase in serum Mg2+ documented in a 
patient with hereditary intolerance to fructose [ 121. 
When the rebound of the liver ATP takes place by 
30 min, the newly formed ATP again binds part of the 
available Mg 2+ This may lower the intracellular free 
Mg2+ level even more. Thus, the situation after fruc- 
tose administration may bear a resemblance to that 
demonstrated in vitro when so-called runoff ribo- 
somes are released from polyribosomes by incubation 
under conditions of amino acid incorporation with 
less than 7 mM Mg2+ [ 13,141. 
In this study, the total ribosomal population was 
examined. It can be further proposed that administra- 
tion of fructose may influence the distribution of ribo- 
somes between free and membrane-bound forms, since 
Mg *+ is thought to play an imp ortant role in the 
ribosome-membrane interaction [ 151. A recent ultra- 
structural study supports this view [ 161. 
Besides being a convenient in vivo system for 
studies on translational control mechanisms of eukary- 
otic protein synthesis, the findings, on the other hand, 
indicate the need for caution when large doses of intra- 
venous fructose are used for various reasons in man. 
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